Aion Therapeutic Stock Analysis
| ANTCF Stock | USD 0.01 0.00 0.00% |
Aion Therapeutic is overvalued with Real Value of 0.0106 and Hype Value of 0.01. The main objective of Aion Therapeutic pink sheet analysis is to determine its intrinsic value, which is an estimate of what Aion Therapeutic is worth, separate from its market price. There are two main types of Aion Therapeutic's stock analysis: fundamental analysis and technical analysis.
The Aion Therapeutic pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Aion Therapeutic's ongoing operational relationships across important fundamental and technical indicators.
Aion |
Aion Pink Sheet Analysis Notes
About 18.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.04. Aion Therapeutic had not issued any dividends in recent years. Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.The quote for Aion Therapeutic is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Aion Therapeutic please contact Graham Simmonds at 416 460 3000 or go to https://www.aiontherapeutic.com.Aion Therapeutic Investment Alerts
| Aion Therapeutic is way too risky over 90 days horizon | |
| Aion Therapeutic has some characteristics of a very speculative penny stock | |
| Aion Therapeutic appears to be risky and price may revert if volatility continues | |
| Aion Therapeutic has high likelihood to experience some financial distress in the next 2 years | |
| Aion Therapeutic has accumulated 643.8 K in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Aion Therapeutic has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Aion Therapeutic until it has trouble settling it off, either with new capital or with free cash flow. So, Aion Therapeutic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aion Therapeutic sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aion to invest in growth at high rates of return. When we think about Aion Therapeutic's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (3.82 M) with loss before overhead, payroll, taxes, and interest of (1.5 K). | |
| Aion Therapeutic has accumulated about 1.85 K in cash with (1.35 M) of positive cash flow from operations. | |
| Roughly 18.0% of Aion Therapeutic shares are held by company insiders |
Aion Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aion Therapeutic's market, we take the total number of its shares issued and multiply it by Aion Therapeutic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 1st of February, Aion Therapeutic shows the Mean Deviation of 39.97, risk adjusted performance of 0.1581, and Downside Deviation of 54.35. Aion Therapeutic technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aion Therapeutic information ratio and the relationship between the maximum drawdown and skewness to decide if Aion Therapeutic is priced correctly, providing market reflects its regular price of 0.011 per share. As Aion Therapeutic appears to be a penny stock we also recommend to validate its total risk alpha numbers.Aion Therapeutic Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aion Therapeutic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aion Therapeutic. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Aion Therapeutic Predictive Daily Indicators
Aion Therapeutic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aion Therapeutic pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Aion Therapeutic Forecast Models
Aion Therapeutic's time-series forecasting models are one of many Aion Therapeutic's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aion Therapeutic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Aion Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Aion Therapeutic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aion shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Aion Therapeutic. By using and applying Aion Pink Sheet analysis, traders can create a robust methodology for identifying Aion entry and exit points for their positions.
Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada. Aion Therapeutic Inc. was incorporated in 2011 and is headquartered in Toronto, Canada. Aion Therapeutic is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Aion Therapeutic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Complementary Tools for Aion Pink Sheet analysis
When running Aion Therapeutic's price analysis, check to measure Aion Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aion Therapeutic is operating at the current time. Most of Aion Therapeutic's value examination focuses on studying past and present price action to predict the probability of Aion Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aion Therapeutic's price. Additionally, you may evaluate how the addition of Aion Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |